CARL
Carlsmed, Inc.
18.60
+3.89 (+26.44%)
52w low 8.50
17.23 high
100.0% of range
Open
16.00
High
19.15
Low
15.20
Prev Close
14.71
Volume
609.57K
Avg Vol 3M
104.45K
Market Cap
507.83M
Currency
USD
6 Month Trend
—
C--
Chg--
Gap--
Vol--
×avg--
σ--
SMA20--
SMA50--
SMA200--
RSI--
SPY--
DD--
Bench--
Sig--
Hist--
pinned · Esc to release
hover · click to pin · ← → step · drag to zoom · shift-drag to measure
—Context
- Move across the chart.
Company
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| Employees | 127 |
| Web | site ↗ |
Performance
1D
+26.44%
5D
+15.60%
1M
+25.85%
3M
+35.57%
6M
+81.82%
YTD
+50.61%
1Y
+52.71%
2Y
--
3Y
--
5Y
--
MAX
+32.29%
Valuation
| P/E Trailing | -- |
| P/E Forward | -10.28x |
| Price / Book | 5.18x |
| Price / Sales | 6.92x |
| EV / EBITDA | -8.74x |
| EPS Trailing | -1.08 |
| Dividend Yield | 0.00% |
| Beta | -- |
Profitability
| Gross Margin | 76.63% |
| Operating Margin | -61.09% |
| Net Margin | -57.42% |
| Return on Equity | -66.14% |
| Return on Assets | -28.19% |
| Revenue Growth | +56.70% |
| Debt / Equity | 0.26x |
| Current Ratio | 8.84x |
Business
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.